Your browser doesn't support javascript.
loading
A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01).
Scott, Aaron J; Basu Mallick, Atrayee; Dotan, Efrat; Cohen, Steven J; Gold, Philip J; Hochster, Howard S; Subramaniam, Somasundaram; Barzi, Afsaneh; Watts, George S; Blatchford, Patrick J; Messersmith, Wells A.
Afiliación
  • Scott AJ; Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, Arizona.
  • Basu Mallick A; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Dotan E; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Cohen SJ; Jefferson Health/Abington Hospital, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania.
  • Gold PJ; Swedish Cancer Institute, Seattle, Washington.
  • Hochster HS; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Subramaniam S; Swedish Cancer Institute, Seattle, Washington.
  • Barzi A; City of Hope Comprehensive Cancer Center, Duarte, California.
  • Watts GS; Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, Arizona.
  • Blatchford PJ; Colorado School of Public Health, Aurora, Colorado.
  • Messersmith WA; University of Colorado Cancer Center, Aurora, Colorado.
Cancer Res Commun ; 2(10): 1188-1196, 2022 10.
Article en En | MEDLINE | ID: mdl-36969746
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Factor A de Crecimiento Endotelial Vascular Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Res Commun Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Factor A de Crecimiento Endotelial Vascular Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Res Commun Año: 2022 Tipo del documento: Article